{"id":"influsplit-ssw","safety":{"commonSideEffects":[{"rate":"10–40","effect":"Injection site reactions (pain, redness, swelling)"},{"rate":"5–15","effect":"Myalgia"},{"rate":"5–10","effect":"Headache"},{"rate":"1–5","effect":"Fever"},{"rate":"5–10","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL4746712","moleculeType":"Unknown","molecularWeight":"887.14"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This vaccine contains inactivated (killed) influenza virus particles that have been split into component antigens, allowing the immune system to recognize and develop antibodies against circulating seasonal flu strains. The split-virion formulation reduces reactogenicity compared to whole-virion vaccines while maintaining immunogenicity. It is administered intramuscularly to provide seasonal protection against influenza A and B.","oneSentence":"Influsplit SSW is an inactivated split-virion influenza vaccine that stimulates immune response against seasonal influenza strains.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:16:05.890Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Seasonal influenza prevention in adults and children"}]},"trialDetails":[{"nctId":"NCT00372255","phase":"PHASE4","title":"Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in Children Aged 6 - 13 Years","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-11-17","conditions":"Influenza","enrollment":240},{"nctId":"NCT01144299","phase":"PHASE3","title":"A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-06-17","conditions":"Influenza","enrollment":114},{"nctId":"NCT00920374","phase":"PHASE3","title":"A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-06-16","conditions":"Influenza","enrollment":118},{"nctId":"NCT01884519","phase":"PHASE3","title":"Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine, Fluarix®/Influsplit SSW® (2013/2014 Season), in Adults 18 Years of Age and Older","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-07-01","conditions":"Influenza","enrollment":120},{"nctId":"NCT01730378","phase":"PHASE4","title":"Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-12-05","conditions":"Influenza","enrollment":131},{"nctId":"NCT00706563","phase":"PHASE3","title":"A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-07-07","conditions":"Influenza","enrollment":120},{"nctId":"NCT00476307","phase":"PHASE3","title":"Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in People 18 Years Old or Above","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-06","conditions":"Influenza","enrollment":120},{"nctId":"NCT01160237","phase":"PHASE3","title":"Study to Evaluate the Immune Response and the Safety of Fluarix TM/ Influsplit SSW® 2010/2011 or Pandemrix TM","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2010-08","conditions":"Influenza","enrollment":7},{"nctId":"NCT00345904","phase":"PHASE3","title":"Study to Evaluate the Safety and Immunogenicity of Fluarix™ 2006/2007 in Adults Aged 18 Years or Above","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-07","conditions":"Influenza","enrollment":120},{"nctId":"NCT00306943","phase":"PHASE3","title":"Annual Study for Fluarix Registration","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-07","conditions":"Influenza","enrollment":120},{"nctId":"NCT00731393","phase":"PHASE3","title":"Immuno & Reacto of TF Trivalent Influenza Split Vaccine 2003/04 or of Std Formulation Influsplit SSW®/Fluarix™ 2003/04","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2003-10","conditions":"Influenza","enrollment":157},{"nctId":"NCT00731029","phase":"PHASE3","title":"Reacto & Immunogenicity of TF Formulation of Influsplit SSW® 2002/03 v/s Std Formulation of Influsplit SSW® 2002/03","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2002-09","conditions":"Influenza","enrollment":239}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Influsplit SSW®","genericName":"Influsplit SSW®","companyName":"GlaxoSmithKline","companyId":"gsk","modality":"Biologic","firstApprovalDate":"","aiSummary":"Influsplit SSW is an inactivated split-virion influenza vaccine that stimulates immune response against seasonal influenza strains. Used for Seasonal influenza prevention in adults and children.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}